Brainsway company info

What does Brainsway do?
Brainsway (TLV:BWAY), (NASDAQ:BWAY) specializes in the development and marketing of advanced neurostimulation treatments for mental health disorders. The company's main focus is on its patented Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive treatment designed to target areas of the brain associated with mood and behavior disorders. Brainsway aims to improve the well-being of patients suffering from a variety of mental health conditions, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction, among others. Through continuous research and development, Brainsway strives to expand the applications of Deep TMS technology to address a wider range of neurological and psychiatric disorders, working towards the objective of offering effective, accessible, and safe treatment alternatives for patients worldwide.
Brainsway company media
Company Snapshot

Is Brainsway a public or private company?

key
Ownership
Public

How many people does Brainsway employ?

people
Employees
134

What sector is Brainsway in?

pie chart
Sector
Health Care

Where is the head office for Brainsway?

location pin
Head Office
Jerusalem, Israel

What year was Brainsway founded?

founded flag
Year Founded
2003
What does Brainsway specialise in?
/Deep TMS /Mental Health /Neuroscience Technology /Depression Treatment /Autism Treatment /Medical Devices

What are the products and/or services of Brainsway?

Overview of Brainsway offerings
Deep TMS Therapy - A non-invasive treatment for depression and OCD using magnetic fields to stimulate brain regions.
Smoking Cessation - TMS technology aimed at helping individuals quit smoking.
Obsessive-Compulsive Disorder Treatment - Offering a specialized TMS coil designed for patients with OCD.
Alzheimer's Disease Management - Developing TMS solutions to alleviate symptoms of Alzheimer's disease.
Anxiety Disorder Treatment - Utilizing TMS to reduce symptoms of various anxiety disorders.
Bipolar Depression Treatment - Tailored TMS protocols to address the depressive phase in bipolar disorder patients.

Who is in the executive team of Brainsway?

Brainsway leadership team
  • Mr. Hadar  Levy
    Mr. Hadar Levy
    Chief Executive Officer
  • Mr. Avner  Hagai
    Mr. Avner Hagai
    Founder & Director
  • Prof. Abraham  Zangen
    Prof. Abraham Zangen
    Co-Founder, Member of Scientific Advisory Board & Director
  • Mr. Christopher J. Boyer Ph.D.
    Mr. Christopher J. Boyer Ph.D.
    Vice President of Global Marketing
  • Dr. Yiftach  Roth Ph.D.
    Dr. Yiftach Roth Ph.D.
    Founder & Chief Scientific Officer
  • Mr. Ido  Marom
    Mr. Ido Marom
    Chief Financial Officer
  • Mr. Menachem C. Klein Esq.
    Mr. Menachem C. Klein Esq.
    VP, General Counsel & Corporate Secretary
  • Dr. Aron  Tendler
    Dr. Aron Tendler
    Chief Medical Officer